Invitation to first half year 2018 presentation

Posted on Aug 23, 2018

Oslo, 23 August 2018 – PCI Biotech invites to a presentation of the company’s second quarter and first half year 2018 report on Thursday 30 August 2018 at Oslo Cancer Cluster Innovation Park. Time: Thursday August 30, 08:30am – 09:30am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation […]

PCI Biotech initiates research collaboration with Bavarian Nordic

Posted on Aug 20, 2018

Exploring synergies between proprietary technologies to further enhance the effect of novel therapeutic applications in cancer and infectious diseases Oslo (Norway) 20 August 2018 — PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that it is initiating a preclinical research collaboration with Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) Kvistgaard, Denmark, a […]

Financial calendar for PCI Biotech Holding ASA

Posted on Jul 10, 2018

Updated financial calendar 2018: Half-yearly Report 2018: 30.08.2018 FINANCIAL YEAR 2018 30.08.2018 – Half-yearly Report 13.11.2018 – Quarterly Report – Q3 Please note that the financial calendar may be subject to changes. Any changes will be communicated.  For further information, please contact: Ronny Skuggedal, CFO,, Mobile: +47 9400 5757 Contact information: PCI Biotech Holding ASA, Ullernchausséen […]